AzTrials
AzTrials

Alveolar OsteitisNCT06435832

Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence

A study testing Absorbable Gelatin, Chlorhexidine and Tranexamic acid in people with Alveolar Osteitis, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This intervention is the treatment of alveolar osteitis (alveolitis) with different effects, which occurs due to the formation of clot after extraction, which is one of the most common intervals after tooth extraction.98 healthy patients with molar and premolar teeth with indication for extraction were taken to the… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Alveolar Osteitis
What is being tested?
Absorbable Gelatin, Chlorhexidine and Tranexamic acid
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 May 2024to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy individuals between the ages of 18-65
  • Molar and premolar teeth with extraction indication

Who cannot join

  • Against drugs or substances to be used in surgery (articaine, tranexamic acid, chlorhexidine) have allergies,
  • Those who used antibiotics 30 days before the dental extraction,
  • Clinical and radiological examinations in the operation area 30 days before dental extraction and/or on the day of the procedure.
  • Any signs of pathology and infection (such as periapical pathology, pericoronitis),
  • Those who routinely use oral antiseptics,
  • Systemic fever, absence of growth such as lymphadenopathy (LAP),
Show all 9Show fewer
  • Women are lactating or pregnant,
  • Using oral contraceptives,
  • Procedures that were not attended to control appointments (day 3-7) were not included.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Recep Tayyip Erdoğan University

    Rize, 53020

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence

This intervention is the treatment of alveolar osteitis (alveolitis) with different effects, which occurs due to the formation of clot after extraction, which is one of the most common intervals after tooth extraction.98 healthy patients with molar and premolar teeth with indication for extraction were taken to the Recep Tayyip Erdoğan University Faculty of Dentistry, Department of Oral and Maxillofacial Diseases and Surgery clinic between May 2024 and June 2024 (age: 38 sessions: 19). -62) 113 teeth (85 molar, 28 premolar teeth) were treated with Spongostan placed in the tooth socket after extraction, spongostan with Chlorhexidine gel and spongostan with tranexamic acid, randomly distributed. After extraction, alveolitis was observed and evaluated prospectively using spongostan, chlorhexidine gel and tranexamic acid in the dental sockets. The researcher checked the participants on the 3rd and 7th days after the tooth extraction. The researcher recorded the pain and edema levels by asking the participants between 0 and 10 using the Visual Analogue Scale (VAS). The researcher filled in the forms for the presence of halitosis, trismus and exposed bone socket on the 3rd and 7th days (YES-NO). Permanent analyzes of the study were created with the SPSS package program.

Being tested
Absorbable Gelatin, Chlorhexidine, Tranexamic acid
Keywords
Alveolar Osteitis
Medical subject headings
Dry Socket

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Absorbable GelatinDrug

    After tooth extraction, only saline irrigation was applied and a absorbable gelatin sponge was placed in the socket.

  • ChlorhexidineDrug

    After tooth extraction, after irrigation with saline, 2% chlorhexidine gel was absorbed into gelatin sponges and placed into the socket.

  • Tranexamic acidDrug

    Tranexamic acid 50mg/ml for injection after saline irrigation after tooth extraction solution into gelatin sponges was applied to the socket after it was cured.

Study groups in NCT06435832
Study groupRoleWhat they receive
just absorbable gelatinActive comparatorAfter tooth extraction, only saline irrigation was applied and a absorbable gelatin sponge was placed in the socket.
Receives: Drug: Absorbable Gelatin
absorbable gelatin with Chlorhexidine gelActive comparatorAfter tooth extraction, after irrigation with saline, 2% chlorhexidine gel was absorbed into gelatin sponges and placed into the socket.
Receives: Drug: Chlorhexidine
absorbable gelatin with tranexamic acidActive comparatorTranexamic acid 50mg/ml for injection after saline irrigation after tooth extraction solution into gelatin sponges was applied to the socket after it was cured.
Receives: Drug: Tranexamic acid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain

    scored on visual analog scale from 0 to 10

    Measured: 3.-7. days

  2. edema

    scored on visual analog scale from 0 to 10

    Measured: 3. day - 7. day

  3. trismus

    marked yes or no based on clinical examination

    Measured: 3. day - 7. day

  4. halitosis

    marked yes or no based on clinical examination

    Measured: 3. day - 7. day

  5. alveolar osteitis

    marked yes or no based on clinical examination

    Measured: 3. day - 7. day

  6. smoking habit

    marked yes or no based on anamnesis

    Measured: operated day

  7. age

    marked yes or no based on anamnesis

    Measured: operated day

  8. tooth type

    marked yes or no based on clinical examination

    Measured: operated day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2024
  2. Study start16 May 2024
  3. Primary completion26 May 2024 (estimated)
  4. Study completion1 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06435832
Sponsor's protocol ID
RTEUni
Status last verified
May 2024
First submitted
20 May 2024
Last updated
30 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gumrukcu Z, Karabag M, Guven SE. The effects of chlorhexidine gel and tranexamic acid application after tooth extraction on the risk of alveolar osteitis formation: a double blind clinical study. Clin Oral Investig. 2024 Aug 21;28(9):494. doi: 10.1007/s00784-024-05886-x.

    PubMed 39167305

Questions about this trial

What is this clinical trial studying?

A study testing Absorbable Gelatin, Chlorhexidine and Tranexamic acid in people with Alveolar Osteitis, run by Recep Tayyip Erdogan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain (time frame: 3.-7. days). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06435832, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in